Results 71 to 80 of about 25,891 (205)

Prolonged Octreotide Therapy in a Neonate with Recurrent Congenital Chylothorax

Indian Pediatrics Case Reports
Background: Congenital chylothorax (CC) is the most common cause of pleural effusion in neonates. While octreotide is a known therapy for this condition, refractory cases usually require high doses of the drug or surgical intervention.
Madhurima Ganguly, Sk Md Habibullah, Bijan Saha   +2 more
doaj   +1 more source

Pheochromocytoma and Diffuse Large B‐Cell Lymphoma in the Ipsilateral Adrenal Gland: A Case Report

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Pheochromocytoma is a catecholamine‐producing tumor arising from the adrenal medulla. When it coexists with a tumor of different origin within the same adrenal gland, it is classified as a collision tumor involving a pheochromocytoma.
Ken Maekawa, Toru Sakatani, Yuki Kita, Kimihiko Masui, Takayuki Goto, Yuki Teramoto, Taisuke Hosokai, Ichiro Yamauchi, Sho Koyasu, Takashi Kobayashi   +9 more
wiley   +1 more source

Comparative analysis of adverse event profiles of lanreotide and octreotide in somatostatin-responsive endocrine and neoplastic diseases

Scientific Reports
Lanreotide and Octreotide are used to treat various endocrine and neoplastic diseases. This study aims to compare the adverse event profiles of Lanreotide and Octreotide in somatostatin-responsive diseases using FAERS data.
Le Wang, Shenglin Chen, Mengying Wu, Lijuan Zhou   +3 more
doaj   +1 more source

Octreotide [PDF]

Journal of Pain and Symptom Management, 2010
Eva, Murphy, Eric E, Prommer, Mary, Mihalyo, Andrew, Wilcock   +3 more
openaire   +2 more sources

Successful Robot‐Assisted Resection of a Retroperitoneal Cystic Tumor With Fluorescent Ureteral Stent and Firefly Imaging

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction We present a technique that combines a fluorescent ureteral catheter with Firefly near‐infrared fluorescence imaging to identify the ureter and avoid injury during robot‐assisted resection of a retroperitoneal cystic tumor. Case Presentation Computed tomography revealed a 6‐cm retroperitoneal cystic mass anterior to the abdominal ...
Yoichiro Tohi, Kana Kohashiguchi, Kenichi Tanaka, Mari Jinno, Takuma Kato, Rikiya Taoka, Nobufumi Ueda, Reiji Haba, Yoshihiro Nishiyama, Mikio Sugimoto   +9 more
wiley   +1 more source

Esophageal Perforation in Zollinger–Ellison Syndrome: A Scoping Review of Management and Outcomes

JGH Open, Volume 10, Issue 1, January 2026.
ABSTRACT Esophageal perforation in Zollinger–Ellison syndrome (ZES) is an exceedingly rare and life‐threatening manifestation of gastrinoma‐related acid hypersecretion. While peptic ulceration and severe reflux are recognized complications of ZES, perforation represents the ultimate consequence of uncontrolled hyperacidity. Evidence remains confined to
Agostino Fernicola, Domenico Parmeggiani, Felice Crocetto, Armando Calogero, Alessio Cece, Domenico Romano, Giacomo Benassai, Gennaro Quarto, Michele Santangelo   +8 more
wiley   +1 more source

Utility of111In-octreotide for the Characterization of an Extra-axial Lesion with uptake of 18F-choline PET-CT in a Patient with Adenocarcinoma of the Prostate [PDF]

, 2020
A. Alvarez-Gracia, Virginia Arroyo, Gabriela Redondo, Sergio Lafuente Carrasco, Anabel Mañes García, Gloria Moragas Freixa, Salvador Villà Freixa, C Davis, K Lee, M Terris, F Fallanca, G Giovacchini, M Picchio, V Bettinardi, C Messa, F Fazio, M Picchio, C Messa, C Landoni, L Gianolli, S Sironi, M Brioschi, M Matarrese, D Matei, F De Cobelli, A Del Maschio, F Rocco, P Rigatti, F Fazio, B Krause, M Souvatzoglou, M Tuncel, K Herrmann, A Buck, C Praus, T Schuster, H Geinitz, U Treiber, M Schwaiger, T Ohtani, H Kurihara, S Ishiuchi, N Saito, N Oriuchi, T Inoue, T Sasaki, N Nathoo, K Ugokwe, A Chang, L Li, J Ross, J Suh, M Vogelbaum, G Barnett, K Bhakoo, S Williams, C Florian, H Land, M Noble, C Welle, E Cullen, P Peller, V Lowe, R Murphy, G Johnson, L Binkovitz, G Giovacchini, F Fallanca, C Landoni, L Gianolli, P Picozzi, L Attuati, M Terreni, M Picchio, C Messa, F Fazio   +75 more
openalex   +1 more source

Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications

Medicinal Research Reviews, Volume 46, Issue 1, Page 203-237, January 2026.
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller, Nadia Bom Pedersen, Vladimir Shalgunov, Andreas Ingemann Jensen, Umberto Maria Battisti, Matthias Manfred Herth   +5 more
wiley   +1 more source

A Multicenter Evaluation of Octreotide for Ventricular Assist Device Related Gastrointestinal Bleeding [PDF]

, 2016
George Smallfield, Sampath Gunda, Sitaramesh Emani, Manreet Kanwar, Nir Uriel, P.C. Colombo, Patricia A. Uber, M.L. Sears, Keyur B. Shah   +8 more
openalex   +1 more source

Systematic review and meta‐analysis of the efficacy and safety of [177Lu]Lu‐edotreotide ([177Lu]Lu‐DOTATOC) for the treatment of neuroendocrine tumors

Journal of Neuroendocrinology, Volume 38, Issue 1, January 2026.
Abstract [177Lu]Lu‐edotreotide is a radiopharmaceutical therapy (RPT) targeting somatostatin receptors, which are commonly overexpressed on neuroendocrine tumors (NETs). This systematic literature review and meta‐analysis describes the efficacy and safety of [177Lu]Lu‐edotreotide in patients with NETs.
Richard P. Baum, Julia G. Fricke, Tristan Ruhwedel, Holger Amthauer, Erika Patricia Azorin‐Vega, Dieter Hörsch, Riccardo Laudicella, Vikalp Maheshwari, Martin A. Walter, Berna Degirmenci Polack, Simon F. Spiegl, Guillaume P. Nicolas   +11 more
wiley   +1 more source